Clinical Trial

Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 31, 2024 (before its estimated July 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study investigates the predictive and prognostic values of inflammatory markers and microRNA in stage IV colorectal cancer. The expression of inflammatory markers and microRNA in plasma will be correlated with tumor location, with dietary patterns and with survival during treatment.
Protocol Amendment History 1 change
critical Trial status changed: Enrolling by Invitation → Unknown 2026-08-02
Trial Details
NCT Number NCT04149613
Lead Sponsor American University of Beirut Medical Center
Conditions Colorectal Cancer Stage IV
Enrollment 100 participants
Start Date 2018-05-25
Primary Completion 2025-07-15 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2024-07-31